| Price | 4.22 |
| Price Change Today | 0.00 (0.00%) |
| P&P rating | ![]() |
| Zacks Rank | 3 - HOLD |
| Open Price | $0.00 |
| Previous Close | $4.22 |
| Daily Range | $0.00 - $0.00 |
| 52-Week Range | $3.41 - $0.00 |
| Volume | 0 |
| Cadence Pharmaceuticals, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. The company currently has two Phase III products in development, including IV APAP, for the treatment of acute pain and fever, and Omigard for the prevention of catheter-related infections. The Company is committed to the fevelopment and commercialization of pharmaceuticals to meet the needs of hospitalized patients and their caregivers. | |





Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment